Document Detail


Detection of D-3-phosphoglycerate dehydrogenase autoantibodies in patients with autoimmune hepatitis: Clinical significance evaluation.
MedLine Citation:
PMID:  21707887     Owner:  NLM     Status:  PubMed-not-MEDLINE    
Abstract/OtherAbstract:
AIM:   D-3-phosphoglycerate dehydrogenase (3-PHGDH) was identified as a putative target of autoantibodies in autoimmune hepatitis (AIH). The aims of the present study were to detect anti-3-PHGDH in patients with AIH and other chronic liver diseases and to analyze their clinical relevance.
METHODS:   Human 3-PHGDH gene was cloned and expressed in Escherichia coli and used in enzyme-linked immunosorbent assays and Western blots. Serum from patients with AIH (n = 101), primary biliary cirrhosis (PBC, n = 122), chronic hepatitis C (CHC, n = 117), chronic hepatitis B (CHB, n = 112), and from patients with other autoimmune disease (n = 125) were investigated.
RESULTS:   The highest incidence and activity of anti-PHGDH was observed in AIH patients. Thirty-two of 40 untreated (80%) and 37 of 61 AIH patients treated with corticosteroid (60.7%) were positive. Antibody titers decreased significantly during corticosteroid treatment. 15.8% of PBC patients, 9.8% of CHB and 12.8% of CHC patients, were anti-PHGDH-positive, with less than 12% of patients positive with other autoimmune diseases via reactions with recombinant 3-PHGDH protein.
CONCLUSION:   Anti-PHGDH were detected in chronic liver diseases. They occur predominantly in AIH, and corticosteroid treatment seems to decrease antibody titers. Whether the antibodies are primary or secondary phenomena and whether they are related to the etiology or pathogenesis, at least in a subgroup of patients with chronic liver diseases, has still to be evaluated.
Authors:
Daijun Xiang; Qing Xia; Dexi Chen; Xia Feng; Yan Zhao; Yan Liu; Huiyu Liao; Yanmin Liu; Ning Li; Huiping Yan
Related Documents :
12360557 - Dopa-responsive parkinsonism phenotype of spinocerebellar ataxia type 2.
17078067 - Computerized posturography balance assessment of patients with bilateral ventralis inte...
1527547 - Improvement of parkinsonian features correlate with high plasma levodopa values after b...
19645057 - Midbrain hyperechogenicity in idiopathic rem sleep behavior disorder.
23418387 - Cyclosporine in anti-jo1-positive patients with corticosteroid-refractory interstitial ...
21308307 - Uvb susceptibility as a risk factor to the development of lepromatous leprosy.
Publication Detail:
Type:  Journal Article     Date:  2011-06-28
Journal Detail:
Title:  Hepatology research : the official journal of the Japan Society of Hepatology     Volume:  41     ISSN:  1386-6346     ISO Abbreviation:  Hepatol. Res.     Publication Date:  2011 Sep 
Date Detail:
Created Date:  2011-09-02     Completed Date:  2013-07-04     Revised Date:  2014-07-30    
Medline Journal Info:
Nlm Unique ID:  9711801     Medline TA:  Hepatol Res     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  867-76     Citation Subset:  -    
Copyright Information:
© 2011 The Japan Society of Hepatology.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Potential of the international scoring system for the diagnosis of Wilson disease to differentiate J...
Next Document:  Cancer preventive effect of pegylated interferon ?-2b plus ribavirin in a real-life clinical setting...